Remnant Lipoprotein-Induced Smooth Muscle Cell Proliferation Involves Epidermal Growth Factor Receptor Transactivation

Circulation

Volumn 108, Issue 21, 2003, Pages 2679-2688

  Kawakami, Akio ^a   Tanaka, Akira ^b   Chiba, Tsuyoshi ^a   Nakajima, Katsuyuki ^c   Shimokado, Kentaro ^a   Yoshida, Masayuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KANTO GAKUIN UNIVERSITY   (Japan)

^c JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

Author keywords

Atherosclerosis; Lipoproteins; Muscle, smooth; Signal transduction

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; REMNANT LIPOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; AORTA MEDIA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FOAM CELL; HYPERTRIGLYCERIDEMIA; INCUBATION TIME; MACROPHAGE; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSACTIVATION;

ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BROMODEOXYURIDINE; CELL DIVISION; CELLS, CULTURED; CHOLESTEROL; EPIDERMAL GROWTH FACTOR; GENES, DOMINANT; HUMANS; LIPOPROTEINS; LIPOPROTEINS, VLDL; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-RAF; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRIGLYCERIDES;

EID: 0345275822     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000093278.75565.87     Document Type: Article

References (24)

1. McNamara JR, Shah PK, Nakajima K, et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis. 2001;154: 229-236.
2. Kawakami A, Tanaka A, Nakano T, et al. Stimulation of arterial smooth muscle cell proliferation by remnant lipoprotein particles isolated by immuno-affinity chromatography with anti-apo A-I and anti-apo B-100. Horm Metab Res. 2001;33:67-72.
3. Kawakami A, Tanaka A, Nakano T, et al. Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions. Circ Res. 2002;91:263-271.
4. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
5. Natarajan V, Scribner WM, Hart CM, et al. Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis. J Lipid Res. 1995;36:2005-2016.
6. Zhao D, Letterman J, Schreiber BM. β-Migrating very low density lipoprotein (βVLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor. J Biol Chem. 2001;276:30579-30588.
7. Argmann CA, Van Den Diepstraten CH, Sawyez CG, et al. Transforming growth factor-1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arterioscler Thromb Vasc Biol. 2001;21:2011-2018.
8. Nakajima K, Saito T, Tamura A, et al. A new assay method for the quantification of cholesterol in remnant like lipoproteins in human serum using monoclonal anti apo B-100 and apo A-I immunoaffinity mixed gels. Clin Chim Acta. 1993;223:53-71.
9. Bradley WA, Hwang SL, Karlin JB, et al. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. J Biol Chem. 1984;259: 14728-14735.
10. Magaud JP, Sargent I, Mason DY. Detection of human white cell proliferative responses by immunoenzymatic measurement of bromodeoxyuridine uptake. J Immunol Methods. 1988;106:95-100.
11. Dent P, Reardon DB, Morrison DK, et al. Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro. Mol Cell Biol. 1995;15:4125-4135.
12. Okabe M, Ikawa M, Kominami K, et al. "Green mice" as a source of ubiquitous green cells. FEBS Lett. 1997;407:313-319.
13. Matsumura T, Sakai M, Kobori S, et al. Two intracellular signaling pathways for activation of protein kinase C are involved in oxidized low-density lipoprotein-induced macrophage growth. Arterioscler Thromb Vasc Biol. 1997;17:3013-3020.
14. Huff MW, Miller DB, Wolfe BM, et al. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans. J Lipid Res. 1997;38:1318-1333.
15. Shah BH, Catt KJ. Calcium-independent activation of extracellularly regulated kinases 1 and 2 by angiotensin II in hepatic C9 cells: roles of protein kinase Cdelta, Src/proline-rich tyrosine kinase 2, and epidermal growth receptor trans-activation. Mol Pharmacol. 2002;61:343-351.
16. Suzuki M, Raab G, Moses MA, et al. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J Biol Chem. 1997;272:31730-31737.
17. Izumi Y, Hirata M, Hasuwa H, et al. A metalloprotease-disintegrin, MDC9/meltrin-γ/ADAM9 and PKCδ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 1998;17:7260-7272.
18. Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402:884-888.
19. Asakura M, Kitakaze M, Takashima S, et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nature Med. 2002;8:35-40.
20. Eguchi S, Dempsey PJ, Frank GD, et al. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. J Biol Chem. 2001;276: 7957-7962.
21. Amour A, Knight CG, Webster A, et al. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett. 2000;473: 275-279.
22. Kalmes A, Vesti BR, Daum G, et al. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res. 2000;87:92-98.
23. Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.
24. Eguchi S, Iwasaki H, Inagami T, et al. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension. 1999; 33:201-206.